Establishment Labs Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Establishment Labs Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Establishment Labs Holdings Inc ESTA.OQ reported a quarterly adjusted loss of 33 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -57 cents. The mean expectation of nine analysts for the quarter was for a loss of 34 cents per share. Wall Street expected results to range from -39 cents to -29 cents per share.
Revenue rose 31.7% to $67.54 million from a year ago; analysts expected $65.77 million.
Establishment Labs Holdings Inc's reported EPS for the quarter was a loss of 39 cents.
The company reported a quarterly loss of $11.75 million.
Establishment Labs Holdings Inc shares had risen by 6.3% this quarter and gained 25.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 0.3% in the last three months.
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Establishment Labs Holdings Inc is $98.00, about 6.9% above its last closing price of $91.25
This summary was machine generated from LSEG data August 6 at 02:10 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2026 | -0.34 | -0.33 | Beat |
Mar. 31 2026 | -0.35 | -0.45 | Missed |
Dec. 31 2025 | -0.22 | -0.09 | Beat |
Sep. 30 2025 | -0.53 | -0.38 | Beat |
Recent news on Establishment Labs Holdings
See all newsU.S. STOCKS ON THE MOVE-Nike, Synopsys, Intel
U.S. STOCKS ON THE MOVE- Cenovus Energy, TeraWulf, Alector
Establishment Labs gains on US FDA approval for more Motiva implant sizes
Brief: Establishment Labs Receives FDA Approval For Additional Sizes Of Motiva Implants
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp